-
Uncategorized1 day agoThe State of Biologics Testing 2026
Read Now The success of modern biologics depends not only on groundbreaking science but on the robustness, speed, and credibility of the testing programs that support...
-
Uncategorized1 day ago
Update: Parabilis raises industry-record $670M IPO
Parabilis Medicines is joining the parade of biotechs going public, with one key difference—more money.
-
Uncategorized1 day agoDOJ reaches second settlement on youth gender care
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Lately, I’ve been listening to the...
-
Uncategorized1 day ago
Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act
The star of the licensing agreement, a small-molecule gamma-secretase modulator, will help buff Eli Lilly’s position in Alzheimer’s disease, currently headlined by its anti-amyloid antibody Kisunla.
-
Uncategorized1 day ago
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China’s Innovent highlights a new type of collaboration;...
-
Uncategorized2 days agoOpinion: Even in abortion-protecting states, teens face unnecessary barriers to care
On May 28 the Nevada Supreme Court made the unanimous decision of halting enforcement of the state’s abortion parental notification law, allowing teens to access abortion...
-
Uncategorized2 days agoSTAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
LONDON — In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting pharma companies and patients across the...
-
Uncategorized2 days ago
Local trade groups must support life sciences in these difficult times
As the industry faces policy changes and significant cuts to federal funding, local ecosystems can bolster companies through innovative resources to sustain growth and keep the...
-
Uncategorized2 days ago
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving...
-
Uncategorized2 days ago
T-Cell Synapse Formation Is Restrained by PTPN22–PSTPIP1 Signaling
T cells don’t simply switch on—they reshape themselves. When these immune sentinels recognize a target, they rapidly reorganize their internal scaffolding to build an immunological synapse,...
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
